Mutation analysis of SHIP gene in acute leukemia.

The SH2 domain containing inositol 5′-phosphatase (SHIP) was initially described as a 145 kD protein phosphorylated on tyrosines upon growth factor and cytokine stimulation. SHIP is predominately expressed in hematopoietic cells, and is a crucial negative regulator in the development of hematopoietic cells. To evaluate the role of the SHIP gene in human leukemogenesis,expression and mutation of SHIP gene in bone marrow and /or peripheral blood from 32 patients with acute myeloid leukemia (AML),9 patients with acute lymphoblastic leukemia (ALL),as well as human hematopoietic cell lines were analyzed by reverse transcription-polymerase chain reaction (RT-PCR),single strand conformational polymorphism (SSCP) and sequencing. The RT-PCR showed that all samples expressed SHIP gene. Mutations of SHIP gene were detected in 7 out of 32 AML patients (22%) and one out of 9 ALL patients (12%). Interestingly, two missense mutations that had been observed in one AML patient at diagnosis disappeared after complete remission (CR). In addition,Akt phosphorylation was prolonged and increased following IL-3 stimulation in this patient sample. In conclusion,data of this study demonstrate the mutation of the SHIP gene in acute leukemia for the first time and suggest a possible role of the mutation of this gene in the development of acute leukemia. SHIP serves as a tumor suppressor by negatively regulating the PI3K/Akt signaling pathway in hematopoietic cells.